12 results
20-F
2020 FY
PRFX
PainReform Ltd
18 Mar 21
Annual report (foreign)
9:03am
and result in a material adverse effect on our business and operations.
We are committed to doing business in accordance with applicable anti-corruption laws … to our planned international clinical trial program could significantly delay our product development efforts.
We are subject to anti-bribery, anti
424B4
PRFX
PainReform Ltd
2 Sep 20
Prospectus supplement with pricing info
4:09pm
-bribery, anti-corruption, and anti-money laundering laws, including the U.S. Foreign Corrupt Practices Act. Violations of such laws could result … anti-corruption laws and our own internal policies and procedures. We also plan to implement policies and procedures concerning compliance with the FCPA
F-1/A
PRFX
PainReform Ltd
31 Aug 20
Registration statement (foreign) (amended)
6:06am
our product development efforts.
We are subject to anti-bribery, anti-corruption, and anti-money laundering laws, including the U.S. Foreign Corrupt … are committed to doing business in accordance with applicable anti-corruption laws and our own internal policies and procedures. We also plan to implement
F-1/A
bhnoc 4h8p7y33z0
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
8dvup
10 Aug 20
Registration statement (foreign) (amended)
4:15pm
F-1/A
ki746snj7diqh69b
5 Aug 20
Registration statement (foreign) (amended)
1:26pm
F-1
7yvr823an5u0r27m7cw9
30 Jun 20
Registration statement (foreign)
5:16pm
DRS/A
5hbuc
2 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
iem lii7ho9jybaspuhh
12 May 20
Draft registration statement (amended)
12:00am
DRS
tsv3 ahbl
3 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next